<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01800474</url>
  </required_header>
  <id_info>
    <org_study_id>05PT1209</org_study_id>
    <nct_id>NCT01800474</nct_id>
  </id_info>
  <brief_title>A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice</brief_title>
  <official_title>A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multe-center, non-interventional study in Europe to evaluate Pliaglis in daily practice
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-center, non-interventional study, including up to 700 subjects at approximately 70
      sites in 5 European countries to evaluate the post-market safety profile of Pliaglis and the
      efficacy of Pliaglis in terms of pain reduction, satisfaction with the product and daily
      practice use prior to pre-defined aesthetic procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-market safety profile of Pliaglis assessed on spontaneously reported Adverse Reactions</measure>
    <time_frame>After Pliaglis application and throughout the site visit (day of application)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of Pliaglis</measure>
    <time_frame>After completing Pliaglis treatment and procedure, i.e. at the end of the site visit (day of application)</time_frame>
    <description>Pain intensity by VAS, satisfaction with pain reduction, willingness to re-use/recommend Pliaglis</description>
  </secondary_outcome>
  <enrollment type="Actual">582</enrollment>
  <condition>Health Knowledge, Attitudes, Practice</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient aiming to perform one or more of the following aesthetic procedures:

          1. Pulsed-dye laser therapy

          2. Laser-assisted hair removal

          3. Non-ablative laser resurfacing

          4. Dermal filler injection

          5. Vascular access
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Patient treated with Pliaglis by the Investigator or other healthcare professional
             according to label (refer to SmPC)

          -  Patient had already consented to receive any one or more of the following aesthetic
             procedures after Pliaglis administration:

               1. Pulsed-dye laser therapy

               2. Laser-assisted hair removal

               3. Non-ablative laser resurfacing

               4. Dermal filler injection

               5. Vascular access

        Exclusion Criteria:

          -  Patient treated with other injectable or topical anaesthetic(s) for the pre-defined
             aesthetic procedure

          -  Previous participation in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Max Murison, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National coordinating investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurizio Podda, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>National coordinating investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugues Cartier, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>National coordinating investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Guillén, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>National coordinating investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Médical Saint-Jean</name>
      <address>
        <city>Arras</city>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt Hautklinik</name>
      <address>
        <city>Darmstadt</city>
        <zip>64297</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Dermatológica Dr. Guillén</name>
      <address>
        <city>Valencia</city>
        <zip>46003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swansea Laser Clinic</name>
      <address>
        <city>Swansea</city>
        <zip>SA7 9FH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2013</study_first_submitted>
  <study_first_submitted_qc>February 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2013</study_first_posted>
  <last_update_submitted>February 27, 2015</last_update_submitted>
  <last_update_submitted_qc>February 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

